Back to Search Start Over

Survival Outcomes for Patients in the QUAZAR AML-001 Trial Who Received Subsequent Therapy for Acute Myeloid Leukemia (AML) after Discontinuing Oral Azacitidine or Placebo

Authors :
Farhad Ravandi
Pau Montesinos
Michael Pfeilstöcker
Cristina Papayannidis
Hervé Dombret
Yinzhi Lai
Erica Petrlik
Thomas Prebet
Hartmut Döhner
Source :
Blood. 140:3277-3279
Publication Year :
2022
Publisher :
American Society of Hematology, 2022.

Subjects

Subjects :
Immunology
Cell Biology
Hematology
Biochemistry

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........867cd59258a79405a434546211227a46

Tools

Authors Abstract Subjects Details